BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10825242)

  • 1. Interruption of NFkappaB-STAT1 signaling mediates EGF-induced cell-cycle arrest.
    Ohtsubo M; Takayanagi A; Gamou S; Shimizu N
    J Cell Physiol; 2000 Jul; 184(1):131-7. PubMed ID: 10825242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells.
    Ohtsubo M; Gamou S; Shimizu N
    Oncogene; 1998 Feb; 16(6):797-802. PubMed ID: 9488044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition.
    Fan Z; Lu Y; Wu X; DeBlasio A; Koff A; Mendelsohn J
    J Cell Biol; 1995 Oct; 131(1):235-42. PubMed ID: 7559780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor-induced growth inhibition requires Stat1 activation.
    Bromberg JF; Fan Z; Brown C; Mendelsohn J; Darnell JE
    Cell Growth Differ; 1998 Jul; 9(7):505-12. PubMed ID: 9690618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.
    Chin YE; Kitagawa M; Su WC; You ZH; Iwamoto Y; Fu XY
    Science; 1996 May; 272(5262):719-22. PubMed ID: 8614832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The level of tyrosine kinase activity regulates the expression of p21/WAF1 in cancer cells.
    Reddy KB; Keshamouni VG; Chen YQ
    Int J Oncol; 1999 Aug; 15(2):301-6. PubMed ID: 10402241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells.
    Jakus J; Yeudall WA
    Oncogene; 1996 Jun; 12(11):2369-76. PubMed ID: 8649777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.
    Johannessen LE; Knardal SL; Madshus IH
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):599-606. PubMed ID: 9895307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells.
    Toyoda M; Gotoh N; Handa H; Shibuya M
    Biochem Biophys Res Commun; 1998 Sep; 250(2):430-5. PubMed ID: 9753647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EGF-induced signal transduction in clonal cells of epidermoid carcinoma A431].
    Grudinkin PS; Bagaeva VV; Nikol'skiĭ NN
    Tsitologiia; 2003; 45(2):158-65. PubMed ID: 12722480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
    Chen B; He L; Savell VH; Jenkins JJ; Parham DM
    Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance between activated-STAT and MAP kinase regulates the growth of human bladder cell lines after treatment with epidermal growth factor.
    Kawamata H; Hattori K; Omotehara F; Uchida D; Hino S; Sato M; Oyasu R
    Int J Oncol; 1999 Oct; 15(4):661-7. PubMed ID: 10493946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor inhibits the growth of TE8 esophageal cancer cells through the activation of STAT1.
    Ichiba M; Miyazaki Y; Kitamura S; Kiyohara T; Shinomura Y; Matsuzawa Y
    J Gastroenterol; 2002; 37(7):497-503. PubMed ID: 12162406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NF-kappaB sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance.
    Anto RJ; Venkatraman M; Karunagaran D
    J Biol Chem; 2003 Jul; 278(28):25490-8. PubMed ID: 12714587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells.
    Gooch JL; Herrera RE; Yee D
    Cell Growth Differ; 2000 Jun; 11(6):335-42. PubMed ID: 10910100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21WAF1.
    Xie W; Su K; Wang D; Paterson AJ; Kudlow JE
    Anticancer Res; 1997; 17(4A):2627-33. PubMed ID: 9252692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected transcriptional signals in normal and mitotically defective cells mediated through cytokine and growth factor receptors.
    Samanta A; Qian X; Greene MI
    DNA Cell Biol; 1995 Nov; 14(11):921-30. PubMed ID: 7576178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
    Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
    Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium.
    Sun L; Carpenter G
    Oncogene; 1998 Apr; 16(16):2095-102. PubMed ID: 9572490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix inhibits apoptosis and enhances endothelial cell differentiation by a NfkappaB-dependent mechanism.
    Wang W; Passaniti A
    J Cell Biochem; 1999 Jun; 73(3):321-31. PubMed ID: 10321832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.